EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay ® Pharmaceuticals, Inc. (NYSE American: NBY) (“NovaBay” or the “Company”) announces the completion of the sale of its Avenova eyecare business and related ...
Stockholders voted to unlock the value of NovaBay’s Avenova ® eyecare business by approving the $11.5 million asset sale Reconvened Special Meeting adjourned to allow additional time for votes to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results